RedShiftBio

RedShiftBio is redefining the possibilities for structural characterization of biomolecules. RedShiftBio has developed a proprietary life sciences platform combining our Microfluidic Modulation Spectroscopy (MMS) and expertise in high powered quantum cascade lasers that provides ultra-sensitive and ultra-precise measurements of molecular structure. These structural changes affect critical quality attributes governing the safety, efficacy, and stability of biomolecules and their raw materials. This combination of technologies is available to researchers in our fully-automated AQS³pro Analyzer and is backed by a global network of sales, applications, service, and support teams to address all market needs. Led by an experienced management team with a proven track record of success in both large instrumentation companies and commercializing disruptive technologies, RedShiftBio is here to support your research and development goals. Our instruments can be found in the majority of the leading biopharmaceutical companies in the world.

News

DKSH Partners With RedShift BioAnalytics in Four Key Markets in Asia Pacific

DKSH has started a new partnership with RedShift BioAnalytics, a leading supplier of life science instruments, to distribute its products in Korea, Taiwan, Singapore, and Thailand.

> Read More

Showing the single result

RedShiftBio – Microfluidic Modulation Spectroscopy (MMS) – AQS³pro
Innovation at Your Fingertips

RedShiftBio’s AQS³pro overcomes many of the limitations of traditional spectroscopy-based technologies with ultrasensitive, highly reproducible, automated structural measurements of proteins and other ...
Innovation at Your Fingertips

RedShiftBio’s AQS³pro overcomes many of the limitations of traditional spectroscopy-based technologies with ultrasensitive, highly reproducible, automated structural measurements of proteins and other biomolecules. It can be used for a wide range of applications from formulation development of mAb-based biotherapeutics to robust measurements of ADCs, AAVs, and mRNA. Powered by Microfluidic Modulation Spectroscopy (MMS), the AQS³pro is designed to provide five key measurements— aggregation, quantitation, stability, similarity, structure—directly supports biomolecule characterization throughout the biopharmaceutical development pipeline.

Key features:
- Ability to measure wide range of native sample concentrations from <0.1 mg/ml to >200 mg/ml
- Fully automated sample-handling, with both 24 and 96 well plate formats
- Real-time background subtraction eliminates need to dialyze samples
- Detection of <2% change in secondary structure even at low concentrations
- Advanced onboard data analytics enabling rapid and robust data interpretation and reporting
Read more